Nanomix: Nanomix Granted CE Mark for eLab S1 Assay Panel for Whole Blood Samples

(marketscreener.com) EMERYVILLE, Calif., May 26, 2022 -- Nanomix Corporation , a leader in the development of mobile, affordable, point-of-care diagnostics, today announced that it has received European CE mark designation for its eLab S1 assay panel for use with a lithium heparinized whole blood sample. The eLab S1 is currently marketed and CE marked for...https://www.marketscreener.com/quote/stock/NANOMIX-CORPORATION-120794213/news/Nanomix-Granted-CE-Mark-for-eLab-S1-Assay-Panel-for-Whole-Blood-Samples-40554353/?utm_medium=RSS&utm_content=20220526